Cambridge Cognition spin-out Monument Therapeutics accesses

Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development  Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that Monument Therapeutics Limited (“Monument”) a p...

Related Keywords

Manchester , United Kingdom , Cambridge , Cambridgeshire , David Poutney James , Freddy Crossley Emma Earl , Matthew Stork , Rupert Dearden , Jenny Barnett , Stephen Symonds , Panmure Gordon United Kingdom Limited , Cambridge Cognition Holdings , Dowgate Capital Limited Joint Broker , Monument Therapeutics Limited , Cambridge Cognition , Monument Therapeutics , Cognition Holdings , Cambridge Angels , Manchester Angels , Chief Executive Officer , Innovate United Kingdom , Chief Financial Officer , Joint Broker , Emma Earl , Corporate Finance , Corporate Broking , Capital Limited , James Serjeant ,